AX·NEWS
Sign in

Biotech & Medtech

Biotech & Medtech news — Sunday 15 November 2026

3 stories from 2 sources, every one in English. Each links to its publisher.

Open in the live feedRSS feedOn a TV

  1. Brain-Focused Startup Oyster Gets $60M to Beat the Size Problem for Small Molecule Degraders
    USMedCity News

    Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli Lilly, maker of the amyloid-targeting Alzheimer’s drug Kisunla, participated in the startup’s new financing. The…

  2. STAT+: FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics
    USSTAT News

    The Food and Drug Administration rejected a treatment for a type of lung cancer developed by the U.S.-based biotech Summit Therapeutics and the Chinese drugmaker Akeso, Summit said on Sunday. In a letter sent to the companies, FDA…

  3. The Zip Code Trap: Why Geography Might Be a Better Predictor of Cancer Survival Than DNA
    USMedCity News

    We are investing billions in making cancer treatment more precise while too many patients still can’t reliably reach the healthcare system delivering it. That should trouble all of us. The post The Zip Code Trap: Why Geography Might Be a…